Supramolecular Gels for Alzheimer's Disease

Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society.

Autorentext

Dr. Mohammadreza Saboktakin is managing director of NanoBMat Research Comapny, GmbH in Germany. He has been published over 13 scientific books in the European and American publications. Also, he has over 45 ISI research papers with high impact factor.